Chapters
Hemolytc disease of the fetus and the newbornPart 1: Overview
General Introduction
Chapter 1
Intrauterine transfusion and non-invasive treatment options for hemolytic disease of the fetus and newborn - review on current
management and outcome Abstract
Part 2: pathogenesis and severity of hemolytic disease of the fetus and newborn
Chapter 2
ABO incompatibility and RhIg immunoprophylaxis protect against non-D alloimmunization by pregnancy Abstract
Chapter 3
Does disease severity always increase in subsequent pregnancies with D immunization?
Chapter 4
The near disappearance of fetal hydrops in relation to current state-of-the-art management of red cell alloimmunization Abstract
Part 3: intrauterine transfusion and other treatment options
Chapter 5
Complications of intrauterine intravascular blood transfusion: lessons learned after 1678 procedures Abstract
Chapter 6
Postponing Early intrauterine Transfusion with Intravenous immunoglobulin Treatment; the PETIT study on severe hemolytic disease of
the fetus and newborn Abstract
Chapter 7
Immunoglobulin for alloimmune hemolytic disease in neonates – a Cochrane review Abstract
Part 4: summary and discussion
Summary and General Discussion